Expression of Gprk2dsRNA.Scer\UAS in the wing under the control of Scer\GAL4MD-638 results in a reduction of the L3/L4 intervein, fusion of the L3 and L4 veins, and in a small proportion of wings, loss of the L3 and L4 veins.
Expression of Gprk2dsRNA.Scer\UAS under the control of Scer\GAL4ptc-559.1 in anterior cells close to the A/P compartment boundary results in disruption to wing veins L3 and L4, and the L3/L4 intervein.
Wing veins are normal in flies expressing Gprk2dsRNA.Scer\UAS in the posterior compartment of the wing under the control of Scer\GAL4hh-Gal4.
Gprk2RNAi.UAS.cMa, Scer\GAL4MD-638 has wing phenotype, enhanceable by smoΔC2.UAS.Tag:FLAG, Scer\GAL4MD-638
Gprk2RNAi.UAS.cMa, Scer\GAL4MD-638 is an enhancer of wing vein L3 phenotype of Scer\GAL4MD-638, hhNIG.4637R
Gprk2RNAi.UAS.cMa, Scer\GAL4MD-638 is an enhancer of wing vein L4 phenotype of Scer\GAL4MD-638, hhNIG.4637R
Gprk2RNAi.UAS.cMa, Scer\GAL4MD-638 is an enhancer of anterior crossvein phenotype of Scer\GAL4MD-638, hhNIG.4637R
Co-expression of smoΔC2.Scer\UAS.T:Zzzz\FLAG and Gprk2dsRNA.Scer\UAS in the wing under the control of Scer\GAL4MD-638 results in a severe wing phenotype.
Expression of Gprk2dsRNA.Scer\UAS in flies expressing hhNIG.4637R in the wing under the control of Scer\GAL4MD-638 strongly enhances the wing vein phenotype.